These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27770740)

  • 41. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
    Jha MK; Minhajuddin A; Gadad BS; Greer TL; Mayes TL; Trivedi MH
    Brain Behav Immun; 2017 Nov; 66():103-110. PubMed ID: 28698115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escitalopram: a review of its use in the management of major depressive disorder in adults.
    Garnock-Jones KP; McCormack PL
    CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Escitalopram (Lexapro) for depression.
    Masilamani S; Ruppelt SC
    Am Fam Physician; 2003 Dec; 68(11):2235-6. PubMed ID: 14677669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personality traits and escitalopram treatment outcome in major depression.
    Aluoja A; Tõru I; Raag M; Eller T; Võhma Ü; Maron E
    Nord J Psychiatry; 2018 Jul; 72(5):354-360. PubMed ID: 29688152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
    Baldwin DS; Cooper JA; Huusom AK; Hindmarch I
    Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment with escitalopram improves the attentional bias toward negative facial expressions in patients with major depressive disorders.
    Zhou Z; Cao S; Li H; Li Y
    J Clin Neurosci; 2015 Oct; 22(10):1609-13. PubMed ID: 26149404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
    Mallinckrodt CH; Prakash A; Houston JP; Swindle R; Detke MJ; Fava M
    Neuropsychobiology; 2007; 56(2-3):73-85. PubMed ID: 18037817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Escitalopram for treatment of major depressive disorder in adults].
    Llorca PM; Brousse G; Schwan R
    Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
    Nordström G; Despiegel N; Marteau F; Danchenko N; Maman K
    J Med Econ; 2010; 13(3):516-26. PubMed ID: 20698748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized, double-blind, 6-week prospective pilot study on the efficacy and safety of dose escalation in non-remitters in comparison to those of the standard dose of escitalopram for major depressive disorder.
    Kim EY; Kim SH; Lee HJ; Lee NY; Kim HY; Park CHK; Ahn YM
    J Affect Disord; 2019 Dec; 259():91-97. PubMed ID: 31445345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In patients suffering from major depressive disorders, quantitative EEG showed favorable changes in left and right prefrontal cortex.
    Haghighi M; Ludyga S; Rahimi B; Jahangard L; Ahmadpanah M; Torabian S; Esnaashari F; Nazaribadie M; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2017 May; 251():137-141. PubMed ID: 28199912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.
    Hunter AM; Cook IA; Greenwald SD; Tran ML; Miyamoto KN; Leuchter AF
    J Clin Neurophysiol; 2011 Oct; 28(5):478-82. PubMed ID: 21946361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA; Andersen HF
    Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Escitalopram prevents relapse in older patients with major depressive disorder.
    Gorwood P; Weiller E; Lemming O; Katona C
    Am J Geriatr Psychiatry; 2007 Jul; 15(7):581-93. PubMed ID: 17586783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.
    Mischoulon D; Price LH; Carpenter LL; Tyrka AR; Papakostas GI; Baer L; Dording CM; Clain AJ; Durham K; Walker R; Ludington E; Fava M
    J Clin Psychiatry; 2014 Apr; 75(4):370-6. PubMed ID: 24500245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.
    Miller JM; Hesselgrave N; Ogden RT; Zanderigo F; Oquendo MA; Mann JJ; Parsey RV
    Biol Psychiatry; 2013 Nov; 74(10):760-7. PubMed ID: 23664414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting.
    Dolberg O; Larsson Lönn S; Kvist K
    Curr Med Res Opin; 2014 Jul; 30(7):1301-7. PubMed ID: 24628498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
    Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis.
    Lam RW; Andersen HF
    Pharmacopsychiatry; 2006 Sep; 39(5):180-4. PubMed ID: 16944409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.